K. Young

First name

K.

Middle name

G.

Last name

Young

Güdemann, L. M., Young, K. G., Thomas, N. J. M., Hopkins, R., Challen, R., Jones, A. G., et al. (2024). Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach. Diabetologia. http://doi.org/10.1007/s00125-024-06190-9

View

Hopkins, R., Young, K. G., Thomas, N. J., Godwin, J., Raja, D., Mateen, B. A., et al. (2024). Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. Bmj Open, 14, e078135. http://doi.org/10.1136/bmjopen-2023-078135

View

Dennis, J. M., Young, K. G., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., et al. (2022). Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit Health, 4, e873-e883. http://doi.org/10.1016/s2589-7500(22)00174-1

View